17 reports of this reaction
3.9% of all ARTICAINE HYDROCHLORIDE AND EPINEPHRINE reports
#1 most reported adverse reaction
ELECTROCARDIOGRAM ST SEGMENT ELEVATION is the #1 most commonly reported adverse reaction for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, manufactured by Benco Dental. There are 17 FDA adverse event reports linking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE to ELECTROCARDIOGRAM ST SEGMENT ELEVATION. This represents approximately 3.9% of all 433 adverse event reports for this drug.
Patients taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE who experience electrocardiogram st segment elevation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ELECTROCARDIOGRAM ST SEGMENT ELEVATION is moderately reported among ARTICAINE HYDROCHLORIDE AND EPINEPHRINE users, representing a notable but not dominant share of adverse events.
In addition to electrocardiogram st segment elevation, the following adverse reactions have been reported for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE:
ELECTROCARDIOGRAM ST SEGMENT ELEVATION has been reported as an adverse event in 17 FDA reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ELECTROCARDIOGRAM ST SEGMENT ELEVATION accounts for approximately 3.9% of all adverse event reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, making it one of the most commonly reported side effect.
If you experience electrocardiogram st segment elevation while taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.